palabra
clave
test
de
viru
respiratorio
de
consumo
de
r
e
u
e
n
lo
viru
son
una
de
la
causa
frecuent
de
adquirida
en
la
comunidad
nac
en
la
precoz
de
viru
respiratorio
supon
una
en
el
consumo
de
estudio
observacion
retrospectivo
desd
enero
del
hasta
junio
del
que
lo
pacient
ingresado
en
un
hospit
terciario
con
de
nac
lo
que
se
test
pcr
viral
en
muestra
respiratoria
resultado
se
incluyeron
episodio
de
nac
viru
respiratorio
en
caso
lo
pacient
con
de
viru
respiratorio
sinciti
vr
presentaron
menor
inicio
de
antibioterapia
vs
p
valour
lo
caso
con
de
vr
influenza
precisaron
menor
de
antibioterapia
recibiendo
el
frent
al
de
lo
que
se
p
pneumonia
signific
caus
morbid
children
year
age
virus
repres
one
main
aetiolog
communityacquir
pneumonia
cap
especi
children
year
age
identifi
cap
set
increas
incid
infect
resist
microorgan
increas
interest
streamlin
prescript
antibiot
advoc
use
case
suspect
confirm
viral
aetiolog
develop
new
microbiolog
diagnost
techniqu
allow
identif
caus
microorgan
less
time
allow
optimis
antimicrobi
consumpt
test
includ
rapid
virolog
diagnost
techniqu
respiratori
sampl
conflict
data
literatur
benefit
techniqu
practic
paediatr
patient
sever
studi
demonstr
use
children
reduc
use
resourc
perform
complementari
test
durat
antibiotherapi
etc
although
other
shown
benefit
main
object
studi
analys
impact
microbiolog
diagnost
test
respiratori
virus
use
antibiot
paediatr
patient
admit
cap
tertiari
hospit
observ
retrospect
singlecentr
studi
conduct
paediatr
patient
year
old
met
follow
criteria
includ
admiss
diagnosi
cap
radiograph
evid
pneumonia
consolid
pulmonari
opac
without
bronchogram
infiltr
interstiti
densiti
pleural
effus
communityacquir
consid
mean
appear
home
case
previou
hospitalis
day
hospit
discharg
within
first
h
hospit
admiss
perform
first
h
admiss
follow
virolog
determin
respiratori
sampl
exud
nasopharyng
aspir
studi
site
influenza
rsv
epidem
tdr
rsv
influenza
respiratori
sampl
perform
protocol
accord
epidem
viru
result
usual
obtain
h
test
neg
viral
mpcr
perform
respiratori
sampl
outsid
epidem
period
mpcr
perform
paediatrician
discret
patient
pneumonia
diagnos
preced
day
exclud
patient
medic
record
review
obtain
demograph
clinic
treatment
evolut
inform
studi
approv
studi
site
ethic
committe
descript
statist
present
absolut
frequenc
percentag
case
categor
variabl
continu
variabl
median
interquartil
rang
iqr
categor
variabl
compar
use
test
fisher
test
appropri
continu
variabl
use
mannwhitney
u
test
stata
analysi
softwar
version
statacorp
texa
unit
state
use
analysi
valu
p
consid
signific
episod
cap
includ
subject
present
differ
episod
girl
median
age
month
ric
medic
histori
present
recurr
bronchospasm
prematur
patholog
histori
rsv
test
perform
case
influenza
test
perform
mpcr
perform
test
perform
case
rsv
influenza
rsv
influenza
test
perform
case
within
h
admiss
mpcr
perform
h
admiss
one
case
case
result
rsv
influenza
test
obtain
within
h
case
result
mpcr
obtain
within
h
admiss
episod
respiratori
viru
identifi
frequent
rsv
children
follow
influenza
children
rhinoviru
metapneumoviru
other
case
singl
viru
identifi
case
differ
virus
case
virus
one
case
virus
frequent
viral
coinfect
rhinovirus
bocaviru
case
rsv
adenoviru
case
blood
cultur
extract
children
isol
microorgan
consid
pathogen
streptococcu
pneumonia
one
case
five
case
associ
pleural
effus
without
requir
drainag
fig
show
start
empir
antibiot
therapi
accord
detect
rsv
influenza
tdr
subsequ
start
hospitalis
case
empir
initi
pneumonia
rsv
influenza
detect
tdr
respect
total
cap
tdr
receiv
antibiot
therapi
tabl
compar
characterist
includ
initi
antibiot
therapi
durat
differ
group
accord
identif
differ
respiratori
virus
notabl
decreas
start
antibiot
therapi
case
rsv
detect
compar
detect
vs
ci
p
addit
case
identif
rsv
influenza
receiv
shorter
durat
antibiot
therapi
receiv
day
continu
variabl
express
median
interquartil
rang
categor
variabl
absolut
frequenc
percentag
p
valu
calcul
use
cap
group
refer
neg
result
virus
evalu
bold
statist
signific
differ
cap
commun
acquir
pneumonia
rsv
respiratori
syncyti
viru
rsv
respiratori
syncyti
viru
case
receiv
antibiot
therapi
count
day
compar
identifi
ci
p
studi
conduct
children
admit
cap
observ
lower
use
antibiot
earli
detect
rsv
respiratori
sampl
similarli
observ
shorter
durat
antibiot
therapi
rsv
influenza
detect
howev
differ
found
detect
respiratori
virus
lack
impact
identif
respiratori
virus
antibiot
therapi
may
due
excess
time
result
obtain
sever
previou
studi
evalu
consumpt
antibiot
use
respiratori
viru
test
similar
result
identif
rsv
hospitalis
children
associ
lower
antibiot
use
studi
subramoni
et
al
compar
period
prior
incorpor
mpcr
respiratori
panel
consecut
period
demonstr
decreas
durat
antibiot
therapi
perform
chest
radiograph
greater
use
isol
precaut
similarli
studi
schulert
et
al
demonstr
decreas
durat
intraven
antibiot
therapi
children
pneumonia
identif
respiratori
viru
mpcr
panel
howev
similar
studi
demonstr
signific
impact
decreas
antibiot
use
children
admit
cap
respiratori
infect
one
difficulti
interpret
detect
respiratori
viru
respiratori
sampl
establish
causal
relationship
clinic
syndrom
sever
studi
detect
respiratori
virus
children
cap
compar
asymptomat
control
shown
greater
associ
identif
influenza
parainfluenza
rsv
metapneumoviru
virus
diagnosi
pneumonia
hand
identif
respiratori
viru
exclud
bacteri
coinfect
bacteri
coinfect
virus
describ
factor
associ
greater
sever
recent
studi
evalu
use
creactiv
protein
differenti
bacteri
pneumonia
pneumonia
produc
rsv
children
year
age
demonstr
adequ
discrimin
capac
limit
studi
retrospect
natur
difficult
assess
detect
respiratori
virus
differenti
infect
colonis
popul
addit
insuffici
statist
power
due
small
sampl
size
preclud
demonstr
signific
differ
sever
comparison
made
advantag
would
highlight
use
strict
inclus
criteria
allow
increas
sensit
detect
respiratori
virus
togeth
specif
radiolog
criteria
addit
noninterventionist
methodolog
follow
allow
evalu
use
techniqu
routin
clinic
practic
conclus
use
respiratori
viru
diagnost
techniqu
set
optimis
use
antibiot
children
admit
cap
decreas
execut
time
mpcr
panel
could
offer
addit
benefit
allow
durat
antibiot
therapi
shorten
moreov
use
predict
model
take
account
detect
respiratori
virus
along
clinic
analyt
paramet
could
improv
identif
children
cap
use
antibiot
safe
dispens
declar
conflict
interest
